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Abstract 
Over the past 50 years, the role of pharmacists has evolved along with the health care needs of our population. In addition to dispensing 
medications and ensuring patient safety, today’s pharmacists are taking a larger role as medical counselors, educators and advocates. 
They are integral part of the health care team, and are among the most trusted and accessible health care professionals. This  
accessibility allows them to perform more patient care activities, including counseling, medication management, and preventive care 
screenings. Beyond the care provided to individual patients, pharmacists have expanded their reach to influence the public health of 
communities. A pharmacist is uniquely positioned to provide disease state management through appropriate medication therapy 
management that has been demonstrated to improve patient outcomes and decrease overall health care costs. This role is more 
important than ever as the environment is demanding new practice and payment models that are required to further optimize care 
and outcomes while addressing the unsustainable increases in health care costs. 
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Introduction 
Pharmacy is the art and science of preparing and dispensing 
medications and the provision of drug-related information to 
the public. It involves the interpretation of prescription orders; 
the compounding, labeling, and dispensing of drugs and 
devices; drug product selection and drug utilization reviews; 
patient monitoring and intervention; and the provision of 
cognitive services related to use of medications and devices. 
The current philosophy or approach to professional practice in 
pharmacy is designated as pharmaceutical care. This concept 
holds that the important role of the pharmacist is “the 
responsible provision of drug therapy for the purpose of 
achieving definite outcomes that improve a patient’s quality of  
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life.” In 2015, the RPS proposed further integration of 
pharmacists into general practices outlining the various 
benefits that pharmacists could provide. Australia, New 
Zealand and Canada have shown positive GP responses towards 
the integration of pharmacists into general practices. GPs 
recognized that having a practice-based pharmacist decreased 
their workload and allowed them to focus on their diagnostic 
and prescribing roles, while pharmacists provided expert 
medication advice and patient counselling. The profession of 
Pharmacy is classically practiced in the three main areas of 
Pharmacy Practice: community, clinical, and hospital. It is now 
generally accepted that the clinic for a pharmacy practitioner is 
not confined to the hospital wards. Every place (even a 
community pharmacy) where medication is used for the 
prevention, diagnosis, and treatment of any clinical condition, 
that is considered to be the interface of pharmacist and patient, 
should be recognized as the pharmacist's clinic. 
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APhA Practice for Pharmaceutical Care 
 Preparation of medications by reviewing and interpreting 
physician orders; detecting therapeutic incompatibilities. 
 Dispensing of medications by compounding, packaging, 
and labeling pharmaceuticals. 
 Controlling medications by monitoring drug therapies; 
advising interventions. 
 Completes pharmacy operational requirements by 
organizing and directing technicians' workflow; verifying 
their preparation and labeling of pharmaceuticals; 
verifying order entries, charges, and inspections. 
 Providing pharmacological information by answering 
questions and requests of health care professionals; 
counseling patients on drug therapies. 
 Developing hospital staff's pharmacological knowledge by 
participating in clinical programs; training pharmacy staff, 
students, interns, externs, residents, and health care 
professionals. 
 Complying with state and federal drug laws as regulated by 
the state board of pharmacy, the drug enforcement 
administration, and the food and drug administration by 
monitoring nursing unit inspections; maintaining records 
for controlled substances; removing outdated and 
damaged drugs from the pharmacy inventory; supervising 
the work results of support personnel; maintaining current 
registration; studying existing and new legislation; 
anticipating legislation; advising management on needed 
actions. 
 Protecting patients and technicians by adhering to 
infection-control protocols. 
 Maintaining safe and clean working environment by 
complying with procedures, rules, and regulations. 
 Maintaining pharmacological knowledge by attending 
educational workshops; reviewing professional 
publications; establishing personal networks; participating 
in professional societies. 
 Contribution towards team effort by accomplishing related 
results as needed [1]. 
 
Exhibit 1. Scholarly Abbreviation of PHARMACIST [2] 
P Patience 
H Honesty 
A Alertness 
R Research 
M Motivator 
A Administrator 
C Courageous 
I Intelligent 
S Studious 
T Thinker 
 
 
Scope of Pharmacists 
A Pharmacist with the above skills and attitudes should make 
himself an indispensable partner in health care system of a 
nation. Pharmacy a complete profession: Pharmacists reflect on 
every sector of society in the form of: 
 Artists – designing a drug dosage form. 
 Lawyer – having fair knowledge of laws and legislation about 
the drug. 
 Engineer - having sound technical knowledge. 
 Entrepreneur - with sound knowledge of management, 
accounting, marketing, Counseling. 
 Health professional - having fair knowledge regarding health 
[2].  
 
Learning “Objectives for the pharmacists” roles in health 
promotion and disease prevention are listed below. 
 Define, compare and contrast the terms health, health 
promotion and disease prevention. 
 Explain the significance of health promotion and disease 
prevention efforts. 
 List and distinguish examples of promotion and prevention 
activities. 
 Describe the need for pharmacist and pharmacy student 
involvement in health promotion and disease prevention. 
 Identify opportunities and challenges for pharmacists to 
provide health promotion and disease prevention services 
[3]. 
 
Academic Pharmacist: In academic pharmacist focus on 
teaching, research and training of the upcoming pharmacist. 
Academic institute are major source of pharmacist, who add 
professional into health care system. By arranging seminar, 
project, or system academics, pharmacist plays valuable role in 
health care system. Academicians identify, educate and train 
student pharmacists to be change agents for the profession so 
they can influence and create more team-based care 
opportunities for pharmacy practice. Academic institutions 
have changed their curricula to meet the future needs of team-
based care for the profession [4].  
 
 
 
 
Figure 1. The Bowtie Phenomenon of Team-Based Care. As 
reform of the US health care system continues, the symbiotic 
relationship between the physician and pharmacist should be at 
the center of the patient care model. The Patient Centered 
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Primary Care Collaborative described the importance of 
focusing on a comprehensive approach to pharmacotherapy 
management in chronic diseases through a team-based 
approach. A visual representation of this approach can be 
thought of as a “bowtie phenomenon”. This bowtie describes a 
relationship in which the diagnostician (physician) and 
pharmacotherapy manager (pharmacist) are able to use their 
specialized training to collaborate with one another. Keeping 
these roles and talents in mind, the pharmacy profession needs 
to train students how to build and be part of effective teams. 
Literature suggests that pharmacists’ perceptions of their 
professional role does not always include describing themselves 
as being in patient-centered roles. However, supporting 
information suggests that pharmacists can contribute to team-
based care (Source: Ferreri SP, Cross LB, Hanes SD, Jenkins T, 
Meyer D, Pittenger A. Academic Pharmacy: Where is Our 
Influence? Am J Pharm Educ. 2017;81(4):63.) 
 
Industrial Pharmacists 
Research and development: Pharmacist contribute to research, 
and their expertise in formulation development is of particular 
relevance to the biological availability of active ingredients. 
Manufacture and quality assurance: The pharmacist’s broad 
knowledge of the pharmaceutical sciences ensures an 
integrated approach to quality assurance (including good 
manufacturing practice) through the validation of the various 
stages of production and the testing of products before release. 
Drug Information: The pharmacist has the knowledge and 
expertise to provide detailed information on medicines to 
members of the health profession and the public. Also, 
pharmacists provide an information service within the 
company. 
Parent Application and Drug Registration: The pharmacist is 
ideally qualified to understand and collate the diverse 
Information required for potent and authorization submissions. 
Clinical Trials and Post–marketing Surveillance: The 
pharmacist has the knowledge of drug and health care 
provision required to facilitate collaboration between 
companies, health professionals and governments in relation to 
clinical trials and surveillance. 
Sales and Marketing: The pharmacist, whose professional 
ethics demand a concern for the interest of Patients, can 
contribute to proper marketing practices related to health care 
and to the provision of appropriate information to health 
professionals and the public. 
Management: The inclusion of pharmacist in all levels of 
management promotes an ethical approach within 
management policies. 
Primary Care Pharmacist/Prescribing Advisors: These are 
people work for NHS organizations that are in charge of a range 
of local. Health services - such as doctor’s surgeries and 
community pharmacies. Their job is to ensure the best use of 
medicines and resources across the area. In Some places, 
practice pharmacist or primary care pharmacist also run 
medication review Clinics and have lots of patient contact. 
Community Pharmacists: Pharmacist work at the frontline of 
healthcare in cities, towns and villages across nation. They work 
from their own pharmacies or out of local healthcare center and 
doctors’ surgeries. Some community pharmacist owns their 
own business and enjoy the challenges of financial 
management and responsibility for staff, stock and premises 
that this brings. Other work for large high street pharmacy 
chain and have the opportunity to move around within an 
established company structure. 
Pharmacist with Special Interest: Pharmacists with special 
interests are involved with developing their skill and expertise 
in specialist areas such as cancer or diabetes. Almost half of all 
pharmacists (42%) offered additional clinical and educational 
Services to community residents including blood pressure 
checks, screening for Cholesterol and osteoporosis, glucose 
screening and diabetes counseling, tobacco Cessation 
programs, immunizations 
Hospital Pharmacist: Hospital pharmacists are a vital part of 
the healthcare term. Working in either the PHC or private 
hospitals, being a hospital pharmacist means your part of a 
team where the focus is firmly on patients (WHO website). 
 
Some pharmacists specialize as consultant (or as pharmacists 
with specialist interests) in many areas as Hematology (blood), 
Nephrology (kidneys), Respiratory medicine, Cardiology (heart), 
Urology (urinary), Diabetes, Gastroenterology (stomach and 
intestine), Infection diseases, pediatrics (children) and care of 
the elderly [5-10]. 
 
The Healthcare Pharmacists 
The World health organization (WHO) report on “The role of the 
Pharmacist in the health care system” states that the 
competence of the Pharmacist is already proven and control.  
A. In health promotion and social responsibilities 
B. In the direction and administrative of pharmaceutical 
services 
C. In drug regulation and control 
D. In the formulation and quality control of 
pharmaceutical products 
E. In the inspection and assessment of drug 
manufacturing facilities 
F. In the assurance of product quality through the 
distribution chain 
G. In drug procurement agencies and 
H. In National and institutional formulary & therapeutics 
committees [11]. 
 
In Health Promotion and Social Responsibilities  
Health promotion is any combination of interventions (i.e., 
health education and related organizational, economic, and/or 
political interventions) designed to facilitate behavioral or 
environmental changes that will improve or protect public 
health. Health promotion strategies focus on community-based 
interventions and partnerships to maintain wellness and to help 
modify individual behaviors, such as unhealthy lifestyles. In 
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other words, health promotion involves community 
interventions that help a person increase control over and 
improve his or her own health. Disease prevention is defined as 
activities that are aimed to prevent and control disease, stop 
the disease processes, or reduce the consequences of disease. 
Disease prevention activities focus on individuals and 
communities with identifiable risk factors that can be targeted 
for effective intervention. Thus, in contrast to health 
promotion, disease prevention efforts emanate more from 
health providers than from individuals. A Pharmacist has an 
important role to play in health promotion and primary, 
secondary and tertiary prevention, especially in relation to the 
management of chronic diseases [12], discussed below in 
details. 
 
 
Figure 2. Beattie’s Model of Health Promotion. Health 
professionals normally lead health persuasion activities. These 
activities are focused at individuals. The approach is 
authoritative and individuals are not given any choices for 
decisions. An example is a pharmacist counselling a COPD 
patient to quit smoking for the sake of his health. Legislative 
actions are interventions initiated by experts or professionals to 
protect the health and welfare of the community. An example is 
the proposed new ordinance to totally ban smoking in 
restaurants and most indoor public areas. Personal counselling 
focuses on the client’s specific needs and normally works on one 
to one basis. The health worker acts as a facilitator to discuss 
and negotiate client needs. Decisions are made based on the 
client’s wishes. For example, the counselor works with drug 
abusers to discuss choices between methadone and 
conventional drug detoxification programs. Community 
development focuses on interventions targeted at the 
community level. The community identifies their health needs, 
seeks to empower and makes the best rational choice (Source: 
Joanne Perks, Maricris Algoso and Kath Peters, Nurse 
practitioner (NP) led care: Cervical screening practices and 
experiences of women attending a women’s health center, 
Collegian, 2018). 
 
 
 
Sexually Transmitted Diseases-AIDS: Huge resource of 
community Pharmacist can educate people in the prevention 
and information of HIV/AIDS. Although many classes of 
antiretroviral are available like protease inhibitors, nucleoside 
reverse transcriptase inhibitors and non-nucleoside reverse 
transcriptase inhibitors, patients need close monitoring and 
strict dietary regimen. Pharmacy is a key player in all the NICE 
publications related to sexual health. They include: 
 Contraception quality standard 
 Contraceptive services for under 25s 
 Long acting reversible contraception 
 One to one intervention to prevent STIs and Under 18 
conceptions [13, 14] 
Pneumococcal disease and influenza: The role of a Pharmacist 
in immunizing adults against pneumococcal disease and 
influenza is discussed. Pneumonia is the leading cause of death 
due to infection worldwide in children aged < 5 years and is 
responsible for approximately 16% of the 5.6 million deaths in 
this population [15]. Pharmacists can promote immunization by 
assuming the roles of educator, facilitator, and immunizer. 
Despite lack of specific mention of it in accreditation standards, 
health-system personnel have a duty to vaccinate adults, just as 
they do pediatric patients. Pharmacists should review 
immunization records with patients periodically and at the time 
of immunization. As with other drug products, formulary 
decisions and the distribution, storage, and handling of vaccines 
are important Pharmacist responsibilities.  
Chronic disease management: A Pharmacist’s role in the 
control of the chronic disease can range from the support of 
proven community programs such as screening and disease 
management clinics for diabetes etc. 
Nutrition Counseling: Pharmacists have unique constellation of 
competencies, including clinical knowledge and skills which 
place them in an ideal position to contribute to the delivery of 
nutrition support therapy to patients. Indeed, the professional 
roles of pharmacists have been evolving from the traditional 
compounding and dispensing of medications to the modern 
delivery of direct patient care within multidisciplinary health 
care teams. Pharmaceutical care (PC) is a practice philosophy, 
in which the pharmacist responsibly provides medication 
therapy to patients to achieve definite outcomes that improve 
their quality of life. There is cumulative evidence to support the 
positive impact of PC on patient care and health care costs [16]. 
Oral Health: A Pharmacist has numerous opportunities on a 
daily basis to positively affect his trend. The American dental 
association has published pamphlets for dentists and 
Pharmacists that cover oral structures and diseases prevention 
to caries, OTC and prescription dental drugs and how these two 
professions can collaborate. 
Environmental Health: About this a Pharmacists should adapt 
his methods of health educations. A Pharmacist role in 
environmental health is related primarily to being alert to the 
conditions prevailing in the community and of working with 
others to adequately control any of the attendant hazards. 
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Epidemiology: Epidemiology is the study of the distribution and 
determination of health-related events in specific population 
and the application of this field in the control of these events. 
Epidemiology relates to the interaction of hosts and their 
environment with attention to those particular agents in the 
environment that are causal factors of disease. The alert 
Pharmacist who can apply the basic principal of Epidemiology 
in their community will become a significant member of the 
health team. 
Health Measurement: A Pharmacist in the health professional 
in the most frequent contact with the general public and this 
function as a community health education makes the 
Pharmacist role unique. By staying abreast of local health 
statistics Pharmacist can function as a valuable resource person 
to researcher’s conduction epidemiological studies in the 
community. 
Health Education: Pharmacists are required more than ever to 
contribute in the area of health promotion (HP), and it is one of 
the six components that contribute to the health improvement 
of individuals accessing pharmacy services as stated in the Joint 
FIP/WHO guideline on good pharmacy practice. The importance 
of the role of pharmacists in patient counseling is recognized 
and because of increased accessibility, they are in a key position 
to provide HP services. Several studies have shown the benefits 
of pharmacists’ involvement in a wide range of important 
public-health issues including smoking cessation, diabetes, 
hypertension and contraception [17] 
Alcohols, Drug Abuse and Smoking Cessation: The diseases of 
alcoholism and drug abuse also come under the preview of the 
community Pharmacist. The Pharmacist has a key role to help 
individuals who become dependent upon alcohol. Counseling 
sessions can be made by the community Pharmacist to stop 
smoking.  
Vaccinations: Administering vaccines to patients and health 
care workers is enabling some health-system Pharmacists to 
assume a prominent role in public health. Pharmacists have 
noticed that immunization needs were not being met and, 
through their advocacy, increased the numbers of patients and 
employees of health systems who have been vaccinated.  
 
 
 
Figure 3. Categories of Pharmacist Immunization Service.  
The NCPA has a free online home-study program, "Creating an 
Immunization Niche in the Community Pharmacy: A Business 
Guide," approved by the Accreditation Council for Pharmacy 
Education for 8 continuing-education contact hours.22 
Practitioners must stay informed about current trends in VPD 
and immunization recommendations.18 Pharmacists who do 
not administer vaccinations may host other health care 
professionals to do so, but they still have an obligation to 
educate and promote full immunization for their patients.18 
While immunizations may be provided upon physician order for 
an individual patient, standing orders or protocols may help 
increase vaccination levels for some VPDs, such as influenza and 
pneumococcal disease. This type of practice is promoted by the 
ACIP (Source: O'Brien KK. Pharmacists' Role in Preventing 
Vaccine-Preventable Diseases. US Pharm. 2009;34(8):39-45.   
 
 
Family planning: Drug shops and pharmacies have long been 
recognized as the first point of contact for health care in 
developing countries, including family planning (FP) services. 
Drug shop operators and pharmacists should not be viewed as 
mere merchants of short-acting contraceptive methods, as this 
ignores their capacity for increasing uptake of FP services and 
methods in a systematic and collaborative way with the public 
sector, social marketing groups and product distributors. 
According to the service delivery guidelines of the Ministry of 
Health and Family Welfare, Government of India, all providers 
dispensing emergency contraception should be appropriately 
informed about emergency contraception and should also 
counsel their clients on regular contraceptive usage [18, 19]. 
 
 
 
 
Figure 4. Spectrum of medication therapy management 
services.  
Patients with a potential need for MTM services can be 
identified by the pharmacist or other healthcare professionals, 
the health plan, or the patients themselves when medication-
related problems are suspected. CPP is accordingly evolving 
within different models including disease management, 
medication therapy management, patient centered medical 
home, and accountable care organizations. Pharmacist roles in 
these models relate to drug therapy management and include 
therapy introduction, adjustment, or discontinuation, patient 
counseling and education, and identification, resolution, and 
prevention of problems leading to drug interactions and adverse 
reactions. Patients may be especially vulnerable to medication-
related problems during transitions of care (e.g. hospital 
admission, hospital to home, hospital to long-term care facility, 
home to long-term care facility such as when their healthcare 
setting changes, when they change physicians, or when their 
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payer status changes. These transitions of care often result in 
medication therapy changes that may be due to changes in the 
patient’s needs or resources, the patient’s health status or 
condition, or formulary requirements. It is important that 
systems be established so that pharmacist-provided MTM 
services can focus on reconciling the patient’s medications and 
ensuring the provision of appropriate medication management 
during transitions of care (Source: Management in Pharmacy 
Practice. Version 2.0 A joint initiative of the American 
Pharmacists Association and the National Association of Chain 
Drug Stores Foundation). 
 
Cholesterol Risk Management: Pharmacist care improves the 
management of outpatients with major modifiable CVD risk 
factors. Pharmacists can help fill the gap as primary care 
providers and can contribute to the control of CVD risk factors 
by their knowledge of medications, their easy accessibility for 
patients, and their collaborative practice with physicians. More 
specifically, pharmacists have the opportunity to provide 
medication instructions to patients at each prescription, to 
improve safe medication use, and to assist physicians in chronic 
care [20]. 
Women Welfare-Pregnancy and Infant Care:  Pharmacists, as 
the most accessible healthcare professionals, can work to 
empower women in their role as informal caregiver s, to 
communicate to women the necessity to be educated and to 
support their health literacy. Furthermore, pharmacists can 
help women to take control of their reproductive health. They 
can help women to develop a reproductive life plan. A 
reproductive life plan consists of personal goals or intentions 
about having or not having children. During and after 
pregnancy, pharmacists can provide women with essential 
education on contraindicated medicines, recommended 
prenatal vitamins and infant feeding options, such as 
breastfeeding and formula feeding [21].   
Individualization of Drug Therapy: Today the latest concept in 
medicine is towards individualization of drug therapy. Where 
judicious patient care is needed individualization of drug 
therapy becomes a need, and a Pharmacist can play a vital role 
in this. A Pharmacist can set up a separate consultation room 
and provide counseling to the patient. He can store the details 
of patient history, allergies and other details necessary for 
therapy so that the concept of individualization of drug therapy 
could be implemented.  
Radio pharmacy: This is a specialized area of pharmacy, where 
radioactive materials are produced as drugs for the diagnostics 
of certain diseases like Thyroid problem by Iodine isotope. Here 
a Pharmacist has a significant role to play. 
Consultancy service: It is another area in where a Pharmacist 
can play a role directly in public health. For independent career 
& business consultancy in pharmacy profession is challenging & 
demanding & has a good scope of successful career build up. 
 
 
 
 
Figure 5. Steps in developing an effective intervention aimed 
at enhancing rational drug use by consumers.  
It provides a framework which links individual drug use behavior 
to the multi-layered environment which shapes it. This includes 
the household level; community level; health service institution 
level; national and international level. The framework described 
provides a basis for the analysis of medicines use problems. It 
can also assist in the development of interventions aimed at 
changing behavior and the environment in which medicines use 
takes place, in order to bring about more appropriate use. The 
framework helps to identify why medicines are used irrationally, 
so that appropriate, effective and feasible strategies can be 
chosen to confront the drug use problems (Source: Essential 
Medicines and Health Products Information Portal. How to 
Investigate the Use of Medicines by Consumers. WHO Web, 
2004). 
 
Rational Use of Drugs: The way drugs are procured, stored, 
distributed, and dispensed and the information given by the 
pharmacist/dispensers dictates the quality of their use, thus in 
terms influencing the rational use of medicines. Different 
models of practice are (1) the drug information practice model, 
(2) the self-care practice model, (3) the clinical pharmacy 
practice model, (4) the pharmaceutical care practice model, 
and (5) the distributive practice model. These models are 
practiced across the continents alone or in combination based 
on the understanding of the local pharmaceutical needs, 
expertise of pharmacist, and their recognition of role [22]. 
Disease prevention: Distinctions between the types of disease 
prevention measures are sometimes unclear. Three levels of 
prevention exist. Here pharmacists play a great role. 
a) Primary: Primary prevention is helping people maintain 
their health or improve the quality of their lives through a 
healthy lifestyle. An example of primary prevention is the 
control of infection through immunization. 
 b) Secondary: Secondary prevention in the early diagnosis and 
treatment of an already existing disease the use of penicillin in 
the treatment of a streptococcal infection prevent the onset 
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of rheumatic fever. Thus, a pharmacist can perform a vital 
service by advising patients, who present a febrile illness 
characterized by a sore throat to see a physician.                              
c) Tertiary prevention: Tertiary prevention largely consists of 
rehabilitation. Most chromic disease cannot be cured but their 
progress can be retarded with maximum benefit to the 
patient. Much can be done for instance with rheumatoid 
arthritis to make patients more comfortable and more 
productive in their daily lives [23, 24].  
Strategic practice-related efforts that could possibly enable 
pharmacists to provide health promotion and disease 
prevention services would include: 
 Knowledge of the clinical and demographic characteristics 
of the community 
 Targeted activities based on assessment of diseases 
associated with the service population in the community 
 Development of a written plan for informational and 
preventive efforts 
 Identification of stakeholders and collaborative community 
partners, such as health departments 
 Community and advocacy groups, homeless shelters, 
institutions, and payers 
 Marketing, documenting, and billing of professional 
services associated with health promotion and disease 
prevention in order to provide sustainable pharmacy-
based interventions; and 
 Utilization of educational materials, e.g., handouts, 
brochures [25]. 
 
In the Direction & Administrative of Pharmaceutical Services: 
In this branch, there are opportunities to a Pharmacist of all 
education levels. The largest numbers of Pharmacists are 
involved in marketing & administration. There are marketing 
people (Pharmacists) educate physicians & community 
Pharmacists, hospital pharmacists etc. about manufactures 
product. This can be a rewarding career for a Pharmacist with 
right personality & motivation.  
 
In Compounding and Dispensing: pharmacists 
 Accept and check prescription details 
 Script validity 
 Safety and appropriateness 
 Review patient’s dispensing history 
 Patient-specific factors 
 Select product 
 Dispensing check 
 Label and assemble dispensed products 
 Supply prescription to patient/carer: re-check 
 Counsel patient/carer on safe and appropriate use  
 
 
 
 
 
 
Table 1. Differences between Dispensing and 
Providing Pharmaceutical Care [26] 
Dispensing Pharmaceutical Care 
Objective is to bring product 
to the customer 
Service business 
Decisions focus on the 
business. 
Objective is to bring the 
pharmacist to the patient. 
Inventory generates revenue. Decisions focus on the patient. 
Available service supports the 
product. 
Patient care generates 
revenue. 
Schedule for repeat 
prescription determined by 
customer supply of drug 
product. 
Available product supports the 
service. 
Business is passively sought 
through the generation of 
prescriptions. 
Schedule for follow-up 
determined by risk and benefit 
of drug therapies and needs of 
the patient. 
Product business Business is actively sought 
through the recruitment of 
patients. 
 
In Hospital Management: A Pharmacist has a great role to play 
in hospital administration. The responsibilities of a hospital 
Pharmacist are to develop a high quality comprehensive 
pharmaceutical service, properly coordinate & meet the needs 
of the numerous diagnostics & therapeutic departments, the 
nursing service, the medical staff, medical equipment of 
hospital & the hospital as a whole in the interest of community 
improving patient care. Clinical pharmacists ‘role in patient 
safety stated below: 
 Hospital pharmacists should take responsibility for the 
management and disposal of waste related to the 
medicine use process, and advise on disposal of human 
waste from patients receiving medicines. 
 Hospital pharmacists should take responsibility for all 
aspects of selection, implementation and maintenance of 
technologies that support the medicine use process, 
including distribution devices, administration devices, and 
other equipment. 
 Hospital pharmacists should ensure appropriate 
assessment, development, implementation and 
maintenance of clinical decision support systems and 
informatics that guide therapeutic decision-making and 
improve the medicine use process. 
 Hospital pharmacists should support the development of 
policies regarding the use or medicines brought into the 
hospital by patients, including the evaluation of 
appropriateness of complementary and alternative 
medicines. 
 Doses of chemotherapy and other institutionally 
identified high-risk medicines should be independently 
checked against the original prescription by at least two 
health care professionals, one of whom should be a 
pharmacist, prior to administration. 
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 Hospital pharmacists should ensure the development of 
quality assurance strategies for medicines administration 
to detect errors and identify priorities for improvement 
 An easily accessible reporting system for adverse drug 
reactions should be established and maintained. 
 An easily accessible reporting system for medication 
errors, including near misses, should be established and 
maintained. 
 Medicines use practices should be self-assessed and 
compared with benchmarks and best practices to improve 
safety, clinical effectiveness, and cost-effectiveness. 
 Systematic approaches (trigger tools) should be used to 
provide quantitative data on adverse drug events and 
optimal medicines use. These data should be regularly 
reviewed to improve the quality and safety of medicines 
practices [27-30]. 
 
 
 
Figure 6. Role of Hospital Pharmacists. Over time, hospital 
pharmacist roles have divided along functional service lines. The 
division across service lines may be unhelpful in achieving a 
paradigm shift from a drug-centered orientation to a patient-
centered orientation. Clinical pharmacy practice, due in part to 
its evolution, offers a blueprint for a patient-centered 
orientation whereby patients (and/or carers) are supported in 
their decision-making about medicines. Clinical pharmacy has 
been defined as the area of pharmacy concerned with the 
science and practice of rational medication use; or more 
elaborately, as a health science discipline in which pharmacists 
provide patient care that optimizes medication therapy and 
promotes health, wellness, and disease prevention.3 Clinical 
pharmacy embraces the concept of pharmaceutical care4 and 
medicines management. All hospital pharmacists therefore 
engage in clinical pharmacy practice. The level and complexity 
of that practice will vary depending on role and experience 
(Source: Olalekan K et.al. Hospital pharmacists’ contribution: a 
perspective. Web Hospital Pharmacy Europe 29 January, 2016). 
 
In Health Maintenance Organizations (HMOs): HMOs are open 
or private associations that give and oversees extensive 
wellbeing administrations to people enlisted. Here a 
Pharmacist can play a role in the administration of this kind of 
organization or give direction. Community pharmacies are very 
frequently the first contact with the health care system, often 
before a General Practitioner. There is a high frequency of 
contacts with low barriers to access to health care: no 
appointments, no long waiting time, convenient opening hours, 
and they are located within the community. Regular contacts 
offer access to a wide range of people, namely, healthy persons, 
those showing symptoms, patients undergoing treatment, 
relatives and other care givers; people from all social strata. It 
would be necessary to pursue relevant policies to enhance the 
utilization of the untapped potentials of community 
pharmacists, especially as primary health care is the central 
focus of health care delivery. Pharmacists can: 
 Perform patient assessment (subjective and objective data 
including physical assessment) 
 Have prescriptive authority (initiate, adjust, or discontinue 
treatment) to manage disease through medication use and 
deliver collaborative drug therapy or medication 
management 
 Order, interpret and monitor laboratory tests 
 Formulate clinical assessments and develop therapeutic 
plans 
 Provide care coordination and other health services for 
wellness and prevention of disease 
 Develop partnerships with patients for ongoing (follow‐up) 
care [31-33] 
 
Extended Role of Community Pharmacists 
Community pharmacists have the potential to not only 
contribute to improving patients’ outcomes through safe and 
effective use of drugs, but also to reduce the cost of healthcare 
by resolving drug related problems and promoting public health 
issues. At the same time, the nature of pharmacy practice and 
community pharmacy is also changing. Along with others, they 
community pharmacists have following responsibilities:  
 Delivery services to household patients 
 Services for groups with special needs 
 Services for residential homes 
 Out of hours services 
 Domiciliary visits 
 Distribution of welfare food 
 Disposal of unwanted medicines 
 Sale of prepayment certificates 
 Hospital discharge and admission procedures 
 Needle and syringe exchange schemes 
 Health promotion activities 
 Health screening 
 Patient referrals to general practitioners and other health 
professionals 
 Development of local formularies 
 Provision of professional advice 
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 Advice on palliative care 
 Supply of disability aids 
 Reporting adverse drug reactions 
 Provision of quiet area for confidential 
 Conversations 
 Supply of complementary medicines [34,35] 
 
 
 
Figure 7. Clinical pharmacy model. The developments of 
supplementary and independent prescribing roles are enablers 
for a multidisciplinary approach to safe and effective use of 
medicines. Researchers have shown the benefits of this 
approach: (1) A study looking at a collaborative approach to 
pharmaceutical care from admission to discharge reported a 
reduced prevalence per patient of error at admission and 
discharge from adult inpatient care; (2) On-ward participation 
of a hospital pharmacist in an intensive care setting has been 
shown to reduce prescribing errors and related patient harm; 
and (3) Pharmacists attending consultant-led ward rounds, in 
addition to undertaking ward pharmacist visits make 
significantly more interventions per patient than those made by 
pharmacists undertaking a ward pharmacist visit alone. The 
increasing use of technology, like electronic prescribing systems 
in hospitals, has affected how the clinical role is discharged. 
Access to drug charts and clinical results outside of the clinical 
areas (or wards) has resulted in some clinical roles being 
discharged off-ward. A number of methods have been described 
for capturing intervention data made by clinical pharmacists 
onwards (Source: Olalekan K et.al. Hospital pharmacists’ 
contribution: a perspective. Web Hospital Pharmacy Europe 29 
January, 2016).  
 
Pharmacists in ICU  
Because of the complexity of drug therapy and the critical 
nature of patients in ICUs, the attendance of a clinical 
pharmacist in this setting is an important issue. Studies have 
reported that the interventions of clinical pharmacists have 
resulted in a rational drug therapy and improved patient care 
and treatment costs [36]. 
Long-term Care: Residents in long-term care are often elderly 
people with several comorbid conditions, who may be very 
susceptible to inappropriate prescribing. Although complex 
medication regimens are often required for these individuals, 
pharmacists can play a vital role in improving the overall quality 
of drug therapy. The pharmacist’s medication review saves 
doctors’ time; this is particularly the case for patients who are 
not reviewed opportunistically. Overall, the evidence for the 
benefit of pharmacists in long-term care settings is quite mixed. 
Pharmacists can improve clinical outcomes by reducing 
potentially inappropriate prescribing and MRPs; however, the 
majority of successful interventions in the literature were 
multidisciplinary in nature. Economic evaluations of pharmacist 
interventions in this setting are limited, but most studies have 
shown no significant difference in humanistic and economic 
outcomes [37]. 
Ambulatory Care Clinics: Ambulatory care pharmacy practice is 
defined as the provision of integrated, accessible healthcare 
services by pharmacists who are accountable for addressing 
medication needs, developing sustained partnerships with 
patients, and practicing in the context of family and community. 
Pharmacist services have varying effects on patient outcomes 
compared with usual care. CPPs deployed at the medical 
center's ambulatory care clinics have had a positive impact on 
clinical and cost outcomes, improving patient care through 
interventions, contributing to readmission reduction efforts, 
generating indirect revenue through cost avoidance, and 
generating new revenue through billing for patient visits [38-
40]. 
 
Exhibit 2. Establishing a New Ambulatory Care Practice Site as a 
Pharmacy Practice Faculty: Key Considerations [101] 
 Have a clear vision of the pharmacist services at the practice 
site 
 Be prepared prior to discussions with the medical director, 
other healthcare providers, and clinic manager, and anticipate 
questions that may arise 
 Ensure that the key stakeholders have a clear understanding 
of the services that the pharmacist will provide to the patients 
at the clinic, and inquire regarding the support and resources 
that the pharmacist can expect from the site 
 Prior to committing to a practice site, gather information 
regarding the feasibility of a successful clinic and seek 
mutually beneficial goals that will provide benefit and value to 
pharmacy students and residents, providers, patients, and to 
the pharmacy practice faculty 
 Regular communication with the providers and staff will help 
identify barriers and help set up a thriving clinical practice site 
 Recognize that establishing a new practice is a difficult 
process, and it may take a considerable amount of time for the 
pharmacist to become fully integrated into the clinic 
 Determine needs versus wants and be prepared to negotiate 
to establish a successful learning environment 
 Be flexible, but if a site is unable to accommodate basic needs 
to set up a successful practice, consider moving on to identify 
other sites 
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Drug Information Services:  Health care providers do not 
actually use these guidelines. Approximately 10% to 40% of 
patients do not receive care based on updated scientific 
evidence and more than 20% of interventions performed are 
not required or are potentially harmful to patients. Drug 
information service is a dedicated and specialized service 
provided by pharmacists to enhance knowledge of medicines 
use, promote rational prescribing among prescribers, and 
reduce medication errors. One of the most important aspects 
of drug information is to be unbiased in its contents. Thus, the 
unbiased nature of information is of paramount importance to 
enhance patient outcomes and reduce ADRs [41, 42].  
In Drug Regulation & Control: A Pharmacist in government 
drug regulatory affair department plays his role by regulating 
the quality of medications, price of the medications, applying 
the ethics & law about medications & industries. 
In the Formulation & Quality Control of Pharmaceutical 
Products: The formulation of any medication is only depended 
on Pharmacist. It is one of the important roles of a Pharmacist. 
The physical, chemical & biological quality of a pharmaceutical 
product intended for administration to patients in the home 
must be of the highest quality attainable. This quality must be 
built in to the product in each step of the aseptic compounding 
process, that is, in the starting components, the design & 
operation of the compounding facilities, the control of the 
environment & the qualifications of operators all contribute to 
the final quality of the product, either in a positive or negative 
manner. Therefore, the control of quality is a continuous 
process throughout the compounding of the product. Testing of 
the finished product can only confirm the quality built in to the 
product during its preparation. Here only a Pharmacist can play 
his role.   
In the Inspection & Assessment of Drug Manufacturing 
Facilities: Another important duty of a Pharmacist (by joining 
the government testing laboratory & medicine regulatory 
service) is inspect the pharmaceutical industries, their 
environment, quality of medications, facilities & assesses the 
medications.  
In the Assurance of Product Quality through the Distribution 
Chain: Distribution of medication is two types— 
a. From industry to market: After produced, before sending 
to the market ensuring the quality of pharmaceutical 
products is must, because it is directly related with life. 
Here only a Pharmacist plays a significant role. 
b. From hospital to the patient (through prescription): The 
medication distribution system in hospitals is very complex 
& involves in several health care professionals. The usual 
flow is physician prescribes, Pharmacist dispenses & nurses 
administer medication. Here the Pharmacist, who 
dispenses, has the right to change the medicine which is 
prescribed by the physician to ensure the quality of that 
medicine. 
 
 
 
In Drug Procurement Agencies: The work of drug procurement 
agencies is to supply the medication & find out the possible 
customer in home & abroad. Here a Pharmacist plays a great 
role. 
In National and Intuitional Formulary and Therapeutics 
Committees: During recent years, with the development of the 
clinical pharmacy movement, a number of clinical Pharmacists 
on the staff of some departments have developed expertise in 
specific therapeutic specially areas. Therefore, it was a logical 
development under the pharmacy & therapeutics committee. 
The formulary system has attempted to outline the scientific 
data on a medication, including its toxicities, untoward side 
effects, safety profile & beneficial effects- has been a 
controversial method of appraising medication therapy. All 
these are provided by a formulary committee of a nation & this 
formulary committee is constructed by the Pharmacists [43, 
44]. 
 
 
 
Figure 8. Core Competency Framework. Competencies refer to 
the knowledge, skills, attitudes and behaviors that an individual 
develops through education, training and work experience. 
When combined, these competencies form a competency 
framework. This framework provides a blueprint for describing 
the competencies and behaviors of pharmacists in their daily 
practice. It is intended that the framework would also be used 
to provide structure and guidance for CPD over the changing 
demands of a pharmacist's career. The framework is divided 
into six domains of practice and identifies a number of 
competencies expected of a pharmacist in each domain. A 
number of behavioral statements are given for each 
competency to demonstrate how individuals who have that 
competency will be behaving in practice. It is used for a number 
of purposes, including: Assisting pharmacists to reflect on their 
practice and identify learning needs for CPD; Development of 
programs by academic institutions; informing the educational 
standards for accreditation by the PSI of pharmacy degree 
programs. Providing a platform for the development of 
specialization and advanced practice within pharmacy. 
Providing a public statement of the professional role of a 
pharmacist (Source: Web Pharmaceutical Society of Ireland 
(PSI). Core Competency Framework) 
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Pharmacist’s Role Plays in Public Health 
Pharmacist contributions to public health that are not widely 
reported. This may be partially due to some of these services 
not being framed within public health categories, so the 
population impact of their services goes unnoticed. Nearly 93% 
of U.S. residents live within five miles of a pharmacy, making 
the community pharmacy one of the most accessible 
healthcare institutions. The pharmacist is in a unique position 
to make essential public health contributions. However, there 
is limited evidence that patient perspectives on the role of 
pharmacists has changed. The role of the pharmacist as part of 
the interdisciplinary team is even more critical in rural locations 
as many of them are healthcare worker shortage areas, and the 
pharmacist may be one of the few healthcare professionals in 
the community [45]. NHS England (NHSE) is facing a growing GP 
workforce crisis, with continuing problems around GP 
recruitment, retention, and retirement rates. Approximately 
30% of GP partners have reported not being able to fill a GP 
vacancy in their practice for at least 12 months (2017-18 
survey). Recent studies support clinical pharmacists in General 
Practice, including their perceived competencies, scope of 
practice, practice environments, levels of integration, and 
support needs [46]. 
 
 
 
Figure 9. Factors of Quality care. Prescription for Excellence 
made a clear commitment to ensuring people had access to 
pharmaceutical care, which was delivered by pharmacist 
independent prescribers across all care settings. Significant 
progress has already been made to build a complementary mix 
of skills within the pharmacy team, including independent 
prescribing, communication skills, history taking and advanced 
clinical assessment skills. A further drive to recruit more 
pharmacists to undertake these programmers, along with an 
increase in training places and additional financial resources, 
will be needed to support the planned capacity increase in 
pharmacists with advanced clinical skills to meet the needs of 
the service (Source: NHS Scotland. Achieving Excellence in 
Pharmaceutical Care a Strategy for Scotland. The Scottish 
Government, August 2017).  
Building Relationships 
Partnerships within pharmacy and public health arenas may 
provide a platform for evidence-based decision making through 
processes that focus on common problems and build a 
foundation for decisions. 
 
Collaboration: IPC is an integral part of the practice of Medicine 
and Family Medicine. The WHO defines IPC as “multiple health 
workers from different professional backgrounds work 
together with patients, families, carers and communities to 
deliver the highest quality of care”. To provide effective, 
patient-centered care, family physicians must collaborate with 
other health and social care providers. There are many benefits 
of collaboration such as enhancing the use of scarce resources 
as many organizations have limited capital, reduction in the 
duplication of cost and effort by decreasing fragmentation of 
health services, improving quality by integrating health 
outcomes for patients, improving communication by 
considering diverse perspectives on public health issues and 
increasing trust and understanding among individuals and 
organizations [47-49]. 
Emergency Preparedness and Response: During the events of 
natural disasters, industrial accidents or bioterrorist attacks, 
healthcare facilities are often over- whelmed by the influx of 
patients. This can lead to inaccuracy or errors in prescribing the 
proper therapy for a patient because of limited staff with little 
time to treat. This is when pharmacists play a critical role in 
individualizing medication therapy regimens to select 
treatment, increase medication effectiveness, and minimize 
adverse drug events. Pharmacy leaders should (1) review 
government and community disaster responses and 
understand the movement of drug supply for each response, (2) 
create a pharmacy disaster plan, (3) list the essential 
medications and determine their inventory levels, and (4) 
establish a staff training program to enhance understanding 
and implementation of the EOP. If successfully developed and 
executed, a hospital pharmacy department’s EOP has a high 
rating of success in meeting patient-centered needs in the 
unforeseen event of a disaster [50]. 
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Figure 10. The Pharmacists’ Patient Care Process. Collect: The 
pharmacist assures the collection of necessary subjective and 
objective information about the patient in order to understand 
the relevant medical/medication history and clinical status of 
the patient. Information may be gathered and verified from 
multiple sources, including existing patient records, the patient, 
and other health care professionals. Assess: The pharmacist 
assesses the information collected and analyzes the clinical 
effects of the patient’s therapy in the context of the patient’s 
overall health goals in order to identify and prioritize problems 
and achieve optimal care. Plan: The pharmacist develops an 
individualized patient-centered care plan in collaboration with 
other health care professionals and the patient or caregiver that 
is evidence-based and cost effective. Implement: The 
pharmacist implements the care plan in collaboration with 
other health care professionals and the patient or caregiver 
[Source: Web Joint Commission of Pharmacy Practitioners 
(JCPP)] 
 
Patient Advocacy: Both hospital and community pharmacists 
have a significant role to play in advocacy of pharmacy as a 
profession. Governments and pharmacy governing bodies are 
continuing to work to increase the scope of practice of 
pharmacists, leaving us with an incredible opportunity to grow. 
Pharmacists also need to be taking responsibility for advocating 
through the interactions we have with patients, other health 
care professionals and the public. In order for pharmacists to 
meet the needs of the medically indigent, further efforts are 
needed to show that the patient’s opinion is valued. Many 
methods can be used to advocate for patients such as 
participation in community collaborations, partnerships, 
consumers’ rights groups, advocacy groups and nonprofit 
organizations which bring communities together for action in 
educating the public and supporting policy changes in public 
health [51].  
Patient Centered Approach (Improving Health Outcomes): The 
mission of pharmacists is to help people achieve optimal health 
outcomes. Similarly, the mission of public health specialists is 
to promote physical and mental health and prevent disease, 
injury, and disability. There is overlap in the two mission 
statements with respect to achieving optimal health outcomes. 
The JCPP created a profession-wide patient-centered care 
model known as the PPCP in 2014. The PPCP recommends that 
pharmacists use a patient-centered approach, in collaboration 
with other health care providers to optimize patient care. To 
accomplish this, pharmacists should use evidence-based 
medicine to collect necessary subjective and objective 
information, assess the collected information, develop an 
individualized patient-centered plan, implement the plan, 
monitor and evaluate the effectiveness of the plan – modifying 
as needed [52]. 
 
 
 
Figure 11. Evidence-based pharmaceutical care. As care 
providers, pharmacists are effective in providing high quality 
patient care and being members in multidisciplinary clinical 
teams is needed to give them the opportunity. Evidence based 
pharmaceutical care is a natural and logical emerging concept in 
the modern pharmacy practice to achieve high quality and more 
effective pharmaceutical care but still more efforts and resources 
are needed to promote new attitude toward more professional 
career. There is strong data showing that pharmaceutical care 
lead to improvement in health outcomes and cost-effective 
therapy. More efforts, policies and qualified staff are needed to 
establish the “evidence-based pharmaceutical care” as new daily 
professional practice. Evidence to support pharmacists in their 
emerging role as care providers is available to improve the 
efficacy and quality of pharmaceutical care. Education and 
specialized training practicing evidence-based approach are vital 
to prepare pharmacists to provide high quality pharmaceutical 
care (Source: Al-Quteimat OM, Amer AM. Evidence-based 
pharmaceutical care: The next chapter in pharmacy practice. 
Saudi Pharmaceutical Journal Volume 24, Issue 4, July 2016, 
Pages 447-451. https://doi.org/10.1016/j.jsps.2014.07.010) 
 
Minimizing Adverse Drug Events: It has been suggested that 
closer collaboration between doctors and pharmacists in 
primary care prevent ADR. Nowadays, pharmacists also ensure 
the rational and cost-effective use of medicines, promote 
healthy living, and improve clinical outcomes by actively 
engaging in direct patient care and collaborating with many 
healthcare disciplines. With this expanding scope of practice, 
pharmacists are being recognized as key components in 
providing individualized patient care as part of 
interprofessional healthcare teams [37]. 
Education and Research: The ACPE and Center for the 
Advancement of Pharmacy Education have encouraged 
collaboration between healthcare professions and pharmacy by 
building the skills and confidence of students to optimize 
patient care and services. They also encourage that pharmacy 
programs “strive to meet community needs” and evaluate 
faculty members for their service contributions to the 
community. Given that emphasis on service, teaching, and 
research are hallmark evaluation metrics of all institutional 
programs, conformance is necessary to develop pedagogical 
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models that are adoptable. In the public health arena, these 
goals of pharmacy practice benefit society by creating desirable 
patient outcomes, minimizing overuse, underuse and misuse of 
medications, and achieving medication related public health 
goals [53]. 
 
Pharmacist on the Home Care Team: Medication-related 
problems are common among home care clients who take 
many medications and have complex medical histories and 
health problems. Helping clients manage medications can be a 
challenge for all home care clinicians. By partnering with a 
college of pharmacy at a large university in the community, the 
agency successfully included a pharmacist as a member of their 
home care team.  Medication-related problems are often 
classified four types: Indication, Effectiveness, Safety and 
compliance [54,55]. 
 
Except these, a Pharmacist has important role to play as Chain 
Drug Store Pharmacist, Grocery Chain Pharmacist, Hospice 
Pharmacist, Hospital Staff Pharmacist, Managed Care 
Pharmacist, Military Pharmacist, Nuclear Pharmacist, Oncology 
Pharmacist, Operating Room Pharmacist, Pediatric Pharmacist, 
Pharmacist in Non-traditional Settings, Pharmacy Benefits 
Manager, Poison Control Pharmacist, Primary Care Pharmacist, 
Psychiatric Pharmacist, Veterinary Pharmacist [56]. 
 
Future Roles 
Revolutionary progress in basic biomedical sciences, including 
human genomics, stem-cell biology, immunology, biomedical 
engineering, and bioinformatics, has provided an 
unprecedented supply of information for improving human 
health. The rapidly emerging fields of population genetics and 
pharmacogenomics highlight the significance of molecular 
techniques in the clinical diagnostic laboratory and the 
potential for application in patient-directed pharmacotherapy. 
Medication-prescribing decisions will increasingly rely on the 
results of genotyping of drug-metabolizing enzymes. New 
technology and practices will allow health system pharmacists 
to reduce treatment failures and prevent adverse drug 
reactions through the proper application of pharmacogenetic 
principles. Advances in informatics will permit aggregation and 
application of population- and patient-specific clinical data in 
ways that will encourage development of population-specific, 
evidence-based disease management programs. As 
medication-use experts, health system pharmacists will need to 
apply these new tools not simply to improve patient-specific 
pharmacotherapy but to advance public health. Similarly, 
innovations in medication delivery technology will allow more 
complex therapies to be administered outside institutional 
settings. Patients, caregivers, and health professionals will 
require education about the safe use of such technologies, as 
will the legislators and other officials responsible for regulating 
their use [57-63]. 
Pharmacy Professional Organizations 
Pharmacy organizations and associations offer many benefits 
to, and can fulfill many needs for, both pharmacists and 
technicians. These groups can offer networking, continuing 
education opportunities, free publications, and leadership 
opportunities. Although some pharmacy organizations are 
specific to just pharmacists, there are many organizations 
available for both pharmacists and pharmacy technicians to 
join, some of which provide specialty information for specific 
pharmacy fields. The Table 2 lists some pharmacy organizations 
and their specialties. 
 
Table 2. Pharmacist Organizations [6] 
Name Description 
APhA National professional organization of pharmacists 
representing pharmacy practitioners, and 
pharmaceutical scientists and students. 
Membership in one of the three academies of the 
APhA are APPM, APRS, ASP—offers members 
specialized benefits and the opportunity to 
influence their practice areas. 
ASHP Professional association of pharmacists who practice 
in organized health care settings. It endeavors to 
create an environment in which pharmacists can 
focus the full potential of their knowledge and 
expertise on patient care to provide high-quality 
pharmaceutical services that foster the efficacy, 
safety, and cost-effectiveness of drug use. 
ASCP Promotes the development and advancement of 
pharmaceutical care activities directed at patients in 
long-term care institutions. 
NCPA Membership in NCPA, formerly known NARD, 
dedicated to the continuing growth and prosperity 
of the independent community pharmacy in the 
United States. 
AAPS The members are eligible for membership in one of 
several disciplinary sections: Analysis and 
Pharmaceutical Quality; Biotechnology; Clinical 
Sciences; Economic, Marketing, and Management 
Sciences; Medicinal and Natural Products Chemistry; 
Pharmaceutical Technology; Pharmaceutics and 
Drug Delivery; Pharmacokinetics, 
Pharmacodynamics, and Drug Metabolism; and 
Regulatory Affairs. 
 
Job market in Developed Countries 
The scope of pharmacist practice is expanding across the world. 
Pharmacist prescribing has taken root in the US, UK and 
Canada. In Alberta, Canada, three types of pharmacist 
prescribing were defined 1) adapting a prescription (i.e., 
adapting an existing prescription or extending a prescription for 
continuity of care, 2) prescribing in an emergency, and 3) 
additional prescribing authority (APA) (i.e., prescribing a new 
medication for initial therapy or to manage ongoing 
conditions). Albertan pharmacists do not require a written 
RE
TR
AC
TE
D
Review PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                        2020, Vol. 11, No. 1, Article 3                       INNOVATIONS in pharmacy 
                                                                             DOI: https://doi.org/10.24926/iip.v11i1.1662 
14 
 
agreement with a physician to prescribe as in the US model. 
Furthermore, pharmacists do not require additional training 
with a physician partner as in the UK model [64]. National 
Center for Health Workforce Analysis, sponsored by the Health 
Resources and Services Administration, projected that between 
2012 and 2025 the pharmacist supply, adjusting for new 
entrants as well as exit from the labor force demand would 
increase by 16%. The BLS estimates an increase of 17,400 jobs 
over 10 years, while there are currently over 14,500 new 
graduates per year. Further, as acknowledged in the HRSA 
forecasting report, greater integration of pharmacists into 
medical teams across a variety of potential settings, along with 
more advanced clinical roles, has the potential to substantially 
boost demand well beyond current expectations [65]. 
Government-subsidized health care facilities in Malaysia 
warrants affordable health care services for the nations, which 
incurs reasonable treatment charges for both standard and 
specialist care. This makes high patient volumes and long 
waiting time a norm in these settings [66]. The integration of a 
pharmacist into private GP clinics has the potential to 
contribute to quality use of medicines. Pharmacists in the public 
health clinics possess complete control over the supply of 
medicines. Collaborative medicines management services 
delivered by pharmacists and GPs have already been successful 
in identifying and resolving medication-related problems, 
improving patient outcomes, and optimizing drug use and 
costs. Such services include pharmacist-led medication reviews, 
where pharmacists assess medications, monitor disease 
progression, and provide recommendations to GPs on a 
medication management plan. Consumers generally supported 
pharmacist integration into private GP clinics [67]. Patients 
expressed concerns that need to be addressed if effective 
diabetes care is to be provided from community pharmacies in 
Malaysia [68,69]. In recent years, a number of countries have 
extended prescribing rights to pharmacists in a variety of 
formats. The latter includes independent prescribing, which is 
a developing area of practice for pharmacists in secondary care. 
Potential opportunities presented by wide scale 
implementation of pharmacist prescribing in secondary care 
include improved prescribing safety, more efficient pharmacist 
medication reviews, increased scope of practice with greater 
pharmacist integration into acute patient care pathways and 
enhanced professional or job satisfaction [70]. NHS England 
(NHSE) is facing a growing GP workforce crisis, with continuing 
problems around GP recruitment, retention, and retirement 
rates. Approximately 30% of GP partners have reported not 
being able to fill a GP vacancy in their practice for at least 12 
months [71]. In July 2015, as part of the Five Year Forward View 
4 and the new deal for general practice, NHSE launched the 
clinical pharmacists in general practice scheme to address 
issues of capacity. The scheme initially provided £31 million 
funding to general practices to employ pharmacists over 3 
years. Phase 1 of the scheme saw approximately 460 
pharmacists employed at around 650 practices across 88 sites. 
In April 2016, NHSE confirmed expansion of the scheme, with 
an additional £112 million for a further 1500 clinical pharmacist 
posts by 2020–2021 [72]. All pharmacists employed through 
the scheme are supported by the Health Education England-
funded GPPTP, an 18-month mandatory training program 
delivered by the CPPE at the University of Manchester [73]. 
 
Success of Pharmacist-led Interventions 
For hospital pharmacists, the expanded scope of practice 
includes activities such as changing drug dosages and other 
aspects of patients’ prescriptions, therapeutic substitution, 
initiation of prescription drug therapy (including therapy for 
minor ailments), and ordering and interpretation of laboratory 
tests, all of which have further focused the pharmacist’s role 
within a patient-centered model of care. Knowledge about 
drugs and diseases and the ability to apply this knowledge are 
key components of success.     Pharmacists are engaged in an 
expanding scope of practice and have dramatic impacts on 
patient and economic outcomes. Reviewing pharmacy 
literature reveals that pharmacist success is driven by 
pharmacist engagement in practice activities and innate or 
cultivated personal characteristics. 
 
In Medication Adherence Improvement and Therapeutic Cost 
Minimization 
Typically, adherence rates of 80% or more are needed for 
optimal therapeutic efficacy [79]. Of the 32 million adult 
Americans who take 3 or more medications daily, 75% are 
nonadherent. Nonadherence accounts for up to 70% of all 
medication-related hospital visits and the estimated annual 
cost of prescription drug-related morbidity and mortality 
resulting from nonoptimized medication therapy was $528.4 
billion in 2016 US dollars" with a low end of $495.3 billion and 
high end of $672.7 billion. The estimated that nonoptimized 
drug therapy results in about 275,689 deaths per year [74-76]. 
In a 2- to 5-minute conversation with patients, pharmacists 
used motivational interviewing techniques to improve patient 
adherence to drug therapy. Results were as follows: 
 Mean adherence rates were improved for all five 
medication classes studied—calcium channel blockers, oral 
diabetes medications, beta-blockers, statins, and renin-
angiotensin system antagonists—in the intervention group 
compared with the control group. 
 Health care costs were lower in the intervention group 
compared with the control group for patients who were 
using oral diabetes medications and statins [77]. 
 Personalized telephone advice from a pharmacist can 
improve medication adherence in patients with long-term 
conditions, research shows [78]. Ultimately, pharmacists’ 
efforts to improve adherence can positively impact patient 
care and generate substantial clinical and financial rewards 
[79]. Studies have shown that ambulatory care and 
inpatient pharmacist medication recommendations are 
well received, with acceptance rates by physicians ranging 
70-90% [80]. 
 
RE
TR
AC
TE
D
Review PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                        2020, Vol. 11, No. 1, Article 3                       INNOVATIONS in pharmacy 
                                                                             DOI: https://doi.org/10.24926/iip.v11i1.1662 
15 
 
In Pediatric Wards 
Clinical pharmacists provide beneficial services to adult 
patients, though their benefits for pediatric hospital patients 
are less defined. Clinical pharmacist services had a positive 
impact on pediatric patient care. Medication errors intercepted 
by pharmacists included over- and under-dosing, missed doses, 
medication history gaps, allergies, and near misses. 
Interventions to address these errors were positively received, 
and implemented by physicians, with an average acceptance 
rate of over 95%. The benefits of pharmacist involvement 
appear greatest when directly involved in ward rounds, due to 
being able to more rapidly identify medication errors during the 
prescribing phase, and provide real-time advice and 
recommendations to prescribers. However, findings from 
systemic review reveals the following: 
 Complex pediatric conditions can require multiple 
pharmaceutical treatments, utilized in a safe manner to 
ensure good patient outcomes  
 The benefits of pharmacist interventions when using these 
treatments are well-documented in adult patients, though 
less so in pediatric patients  
 Pharmacists are adept at identifying and managing 
medication errors for pediatric patients, including incorrect 
doses, missed doses, and gaps in medication history.  A 
prospective study by Fortescue et al. showed that ward-
based clinical pharmacists prevented 81% of potentially 
harmful medication errors. 
 PPAG endorses and advocates for the involvement of 
pediatric pharmacists in pharmacogenomic testing and in 
using those results to provide safe and effective 
medication use in pediatric patients of all ages. 
 Interventions recommended by pharmacists are generally 
well-accepted by prescribing physicians, especially when 
recommendations can be made during the prescribing 
phase of treatment 
 Increased pharmacist presence in the PICU is associated 
with increased interventions and prevention of adverse 
drug events. Pharmacist participation during rounds and 
order entry substantially improved the care of critically sick 
children and should be encouraged. 
 Clinical pharmacist-initiated education resulted in 
improved medication understanding and adherence, 
improved patient satisfaction, and control of chronic 
medical conditions [81-87]. 
 
Chronic Disease Management 
A research that was done in Katmandu showed that 44% of the 
community pharmacy professionals always counseled on the 
importance of exercise and diet control. These findings are also 
consistent with a study in Scotland [88]. Since diabetes is a 
chronic lifelong condition, adherence to medications and self-
monitoring of blood glucose are quite challenging to the 
patients. ADA recommend that HbA1c should be measured at 
regular intervals in all patients with diabetes. Impact of 
diabetes self-care intervention by pharmacist reported to 
significantly reduce the HbA1C levels of diabetic patients along 
with the reduction of yearly healthcare cost [70]. Another study 
presented that an adequate duration of pharmacist-led 
pharmaceutical care was effective in improving HbA1c in 
patients with diabetes in both LMIc and Hic [89, 90]. CVD is the 
major cause of death in patients with diabetes and is about two 
times more frequent in these patients compared with people 
without diabetes. Pharmacist care improves the management 
of outpatients with major modifiable CVD risk factors. 
Pharmacists can help fill the gap as primary care providers and 
can contribute to the control of CVD risk factors by their 
knowledge of medications, their easy accessibility for patients, 
and their collaborative practice with physicians. Pharmacist 
care was associated with significant reduction in blood pressure 
and serum cholesterol and a reduction in the risk of smoking. It 
has been evaluated and documented that pharmacists 
providing medication reconciliation especially during transition 
of care, educating patients on their medications, and providing 
collaborative medication management lead to positive changes 
in the patient outcomes, including but not limited to decreasing 
in hospitalizations and re-admissions [91-93]. Through a 
combination of educational and organizational support, a 
general practice-based pharmacist led collaborative 
intervention can improve statin prescribing and achievement of 
cholesterol targets in a high-risk primary care-based population 
[94]. 
 
Medication History Taking, Error prevention and Reconciliation 
As it was discussed earlier that about 30%–40% of patients 
receive treatment that is not based on scientific evidence, and 
20%–25% receive treatments that are either not needed or 
potentially harmful. In addition, it is estimated that more than 
50% of Americans do not take medications as they are 
prescribed, and approximately one third do not finish the 
course of therapy or skip doses [95]. In the USA, it has been 
reported that 3.7% of all hospitalized patients experienced an 
adverse event, and medication errors alone resulted in 7000 
deaths annually. The average health expenditure per person in 
sub-Saharan Africa countries is below US$100 per annum 
compared with US$6110 in Australia and US$9146 in USA, while 
1.5–6.5% of hospital admissions are attributed to ADEs and 2.5–
47% of inpatients encountered an ADE during their hospital 
stay. One-fifth to more than a half of the reported ADEs were 
severe events, of which ADE related fatalities were reported in 
0.07–2.9% of patient admissions to hospital [96]. More than 
25% of medication errors can be attributed to incorrect 
medication histories, demonstrating that this is an error-prone 
process. More than 33% of patients had at least one medication 
discrepancy at admission, and 85% of these originated from the 
medication history. Greater than 97% of medication histories 
documented by health care providers other than pharmacists 
were associated with at least one medication discrepancy. 
Medication discrepancies, within the medication reconciliation 
process, occur in approximately 70% of admitted and 
discharged patients, 29.5% of which can lead to harm and ADEs 
RE
TR
AC
TE
D
Review PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                        2020, Vol. 11, No. 1, Article 3                       INNOVATIONS in pharmacy 
                                                                             DOI: https://doi.org/10.24926/iip.v11i1.1662 
16 
 
[99]. Pharmacy technicians have been shown to reduce 
medication list discrepancies as part of various medication 
reconciliation programs [97]. Obtaining an accurate medication 
history during transitions of care has been shown to reduce 
errors that could lead to patient harm and is the foundation of 
the medication reconciliation process.  Use of a pharmacy 
technician may provide the benefits of pharmacist-based 
medication history collection while being financially 
advantageous. Cooper and colleagues discussed the 
advantages of a standardized pharmacy technician medication 
history program that helped improve provider compliance with 
discharge medication reconciliation [98]. Overall, pharmacy 
technicians were more effective in executing the logistical 
details of the service, seeing more patients, and clarifying the 
drug and route as well as removing discontinued and duplicate 
medications from the list more often [97]. Involvement of 
pharmacy personnel during the medication reconciliation 
process can be an essential component in reducing medical 
errors. With the addition of the pharmacy department during 
the admission process, accuracy, cost savings, and patient 
safety across all phases and transition points of care were 
achieved [100]. 
 
Conclusion 
As the health care system changes, the line between the roles 
of pharmacist and physician can become blurred. What 
differentiates a pharmacy role from a medical role? A simple 
answer is that what the state licensing laws allow each 
profession to perform provides that differentiation. However, 
over my 50 years in practice, legislative changes in practice acts 
have tended to blur the differentiation. When you recommend 
a treatment for the problem, you are acting as an independent 
practitioner. As the FDA and some states move toward a class 
of drugs that pharmacists can prescribe/recommend, the line 
between physician and pharmacist blurs yet again” --Fred M. 
Eckel, Editor-in-Chief, Pharmacy Times. From the above 
consideration, it is clear that the Pharmacists have definite 
beneficial roles regarding health matters. A Pharmacist is the 
legally qualified and professionally competent person to handle 
drugs and allied supplies required for the patients within and 
outside the hospital. It is a matter of regret that the 
government of our country is taking very little effort to employ 
highly skilled pharmacy personnel in different sectors of the 
health services. But in the developed countries, Pharmacists are 
in unique position in this regard. So, the governmental health 
policy should be modified by incorporation Pharmacist in 
different s. The huge divides that exist in patient education and 
income levels can be alleviated by design and use of cost-
effective educational materials and the visual media. The 
development and empowerment of the pharmacist can occur 
only if appropriate steps are taken to ensure that pharmacy 
licenses are awarded only to qualified pharmacy graduates and 
adequate educational training is imparted so that pharmacists 
remain and are rewarded for being the best sources of 
information related to medication use. Successful policies in 
this regard and implementation of appropriate regulation will 
ensure the development of a safer and more effective 
pharmaceutical public health system, which can in turn, directly 
translate to improved health of all citizen sectors to improve 
and ensure the health service for the well-being of people of 
our country. 
 
Article Summary 
Pharmacy is the art and science of preparing and dispensing 
medications and the provision of drug-related information to 
the public. It involves the interpretation of prescription orders; 
the compounding, labeling, and dispensing of drugs and 
devices; drug product selection and drug utilization reviews; 
patient monitoring and intervention; and the provision of 
cognitive services related to use of medications and devices. The 
current philosophy or approach to professional practice in 
pharmacy is designated as pharmaceutical care. This concept 
holds that the important role of the pharmacist is “the 
responsible provision of drug therapy for the purpose of 
achieving definite outcomes that improve a patient’s quality of 
life.” Pharmacists, then, are those who are educated and 
licensed to dispense drugs and to provide drug information—
they are experts on medications. They are the most accessible 
member of today’s health care team, and often are the first 
source of assistance and advice on many common ailments and 
health care matters. 
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